Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07462715) titled 'Statins Against Bushfire Smoke' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: Menzies Institute for Medical Research

Condition: Healthy Adults

Intervention: Drug: Atorvastatin

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: May 1, 2026

Target Sample Size: 100

Countries of Recruitment: Australia

To know more, visit https://clinicaltrials.gov/study/NCT07462715

Published by HT Digital Content Serv...